Collective invasion into adjacent tissue is a hallmark of luminal breast cancer, with about 20% of cases that eventually undergo metastasis. 
Introduction
The challenge to understand the nature of tumor cells that initiate metastases is of great clinical significance. Invasion into adjacent tissue often followed by metastasis is a hallmark of breast cancer (BrCa). Growing evidence showed that the metastatic dissemination of epithelial breast tumors can occur in a manner as collective cells (Friedl et al, 2012) without activation of the epithelial-mesenchymal transition (EMT) program (Fischer et al, 2015; Zheng et al, 2015) , in which cancer cells locally invade the peritumoral stroma as cohesive clusters while maintaining cell-cell junctions, even traveling as clustering circulating-tumor cells (Aceto et al, 2014; Yu et al, 2013 )and more efficiently seeding to form metastases than single circulating tumor cells (Cheung et al, 2016; Zajac et al, 2018) . EMT models could not adequately describe the invasive behaviors of breast cancer cells in collective movement (Shamir et al, 2014) . The nature of the cancer cells that give rise to cohesive invading is still poorly understood.
At the onset of collective cell invasion, a subset of cancer cells appear at the leading edge acquires a distinct phenotype with characteristic morphology and motility. It was revealed that basal genes, such as cytokeratin 14 (K14) or p63 (Cheung et al, 2013) , and some signaling moleculars, such as Erk1/2 and RhoA located at the leading front cells (Chapnick & Liu, 2014; Reffay et al, 2014) . Those leading cells can facilitate invasion by forming invasive protrusions, which provide traction and trigger modifications of the ECM in leader-follower cooperative manner (Nguyen-Ngoc et al, 2012) . It is more of challenge for epithelial cancers to drive leader cell formation and initiate cell spread in a collective manner. The ability to acquire a distinct "leader" phenotype varies among different tumor cell populations originally derived from different patients with individual intracellular and extracellular microenvironment (Liu et al, 2013) , (Dang et al, 2011; Nguyen-Ngoc et al, 2012) . The mechanisms of how collectively cell invading into the surroundings was triggered are still not clearly understood.
Clinically, breast cancers are heterogeneous, often containing multiple subpopulations of cancer cells with distinct molecular states (Almendro et al, 2013; McGranahan & Swanton, 2015) , which are likely to be plastic and adaptive to microenvironment stimuli. The heterogeneity and plasticity in mammary epithelial cell may cause poor response to endocrine therapy (Ito et al, 2015) and high risk of metastasis (Kennecke et al, 2010) , although a more favorable prognosis could be expected in most of luminal breast cancers. Understanding how these subpopulations in luminal epithelial cells, though displaying less invasive than basal like BrCa cells, acquire phenotypic changes and enable an enhanced invasive ability to metastasis is of great importance.
Here, we investigated the switch of phenotypic states in subpopulations in epithelial breast cancer induced by the shift of CD44 levels during collective cell invasion. The phenotypes of cancer cell were showed to be dynamic and plastic (Friedl & Alexander, 2011; Matak et al, 2017) , and a dynamic conversion between CSCs and Non-CSCs was also revealed (Iliopoulos et al, 2011) . CD44, as a mesenchymal marker, was used to identify cancer stem cells, and also contributed to regulate tumor stemness and metastasis (Ahmed et al, 2016) . Interconversions between CSCs and Non-CSCs were usually happened that illustrating the dynamic and plastic of cancer cell phenotypes (Friedl & Alexander, 2011; Matak et al, 2017) , 23 . Switch in expression pattern of CD44 standard (CD44s) and variant isoforms (CD44v) has been shown to influence EMT process, but functional significances of CD44 variants are not yet fully understood (Brown et al, 2011; Preca et al, 2015) . Nevertheless, the involvement of CD44 in leader cell formation during epithelial collective invasion has not been studied. We therefore observed the inducible and exchangeable acquirement of CD44
along with other leader cell features, and monitored the formation of leading tips during collective migration. Our results revealed that the plasticity and ability of epithelial cancer cells, CD44 lo -to-CD44 hi conversion, generate invasive leading cells, which might be contribute to the transition from in situ to invasive behavior of luminal-type BrCas.
Results

CD44 is a featured molecular of leading cells during collective invasion in breast cancers
To investigate intratumor heterogeneity related to CD44 expression during progression in breast carcinoma, we performed immunohistochemistry analysis of 247 human breast tumors of different molecular subtypes, 30 of which containing the tumor-stromal interface of the invasive edge. We analyzed the tumors for the expression of CD44 in 41 luminal A, 92 luminal B, 44 HER2+, and 70 triple negative (TN), as defined by immunohistochemical analysis. Interestingly, at the tumor-stromal interface in all four molecular types, multicellular groups of cells were revealed invading into the adjacent stroma (Fig. 1A) . Remarkably, the level of CD44 was significantly upregulated in the edge of leading cells in the invading strands, but not in other cells in the inner region of the collective clusters (Fig. 1A) . The frequency of CD44 hi cancer cells is correlated with the clinical molecular subtypes, displaying the highest in triple negative and the lowest in luminal-like cases examined (Fig. 1B and   Supplemental Table S1 ), which is consistent with previous studies (Park et al, 2010) .
No significant differences were detected when the level of CD44 hi cell was compared between luminal-A and luminal-B cases (P = 0.9301) (Fig. 1B and Supplemental Table S1 ).
Similar to clinical tumor tissues, in orthotopic xenografts in mice, CD44 was also enriched at the invading boundary in luminal-like primary breast tumor and lung metastases (Fig. 1C) . Also, immunostaining assay further indicated that cancer cells with CD44 high levels were located at migrating tips during collective movements in luminal-like breast cancer cells ( Fig. 1D and Fig.S1 ). Follower cells at the inner region during collective migration, however, presented only low levels of CD44. 
CD44 hi cells led collective invasion of luminal breast cancer cells
To observe the migration of CD44 hi cells and CD44 lo cells, we cultured two confluent epithelial monolayers within two confined wells separately and then remove the confinement, triggering cluster migration in the forward facing direction (Fig.3A) as modified from previous report (Das et al, 2015) . As a result, 3,826 genes were differentially expressed between the two subsets (R2-fold; p < 0.05) (Fig.S3A, B) . Unsupervised hierarchical clustering of differentially expressed genes was involved in three major pathways: focal adhesion, EMT and RAS signaling pathway.
To address the factors underlying the different phenotypes, we analyzed the most significantly changed genes bioinformatically. Gene Ontology (GO) and KEGG functional enrichment analysis revealed 10 distinct terms enriched in the CD44 hi cells (Fig. S3C ). According to the high invasiveness in CD44 hi cells, several genes related to cell motility and modifiers of the extracellular microenvironment were among the most differentially expressed genes, with lower levels in the CD44 lo cells, including MMP2, MMP9, Plau, CLDN-1, -3, -11, and -7. Moreover, the CD44 hi cells expressed a number of mesenchymal markers not present in CD44 lo cells (Fig. 3E ), including reduction of epithelial markers including CDH1 (E-cadherin), JUP (γ-catenin), krt8, and krt18 and increase of mesenchymal markers including FN1 (fibronectin), Vim (vimentin), COX-2(Ptgs2), and ZEB2. This was confirmed by quantitative real-time PCR (qRT-PCR) (Fig. 3F) . However, how the CD44-associated invasive gene set revealed in CD44 hi subset coordinates with each other and contributes to collective invasion are unknown.
Next, we investigated the localization of some additional mesenchymal markers that might explain the sustained invasion of carcinoma cells (Fig.3G) . Surprisingly, besides the difference of E-cadherin RNA expression between CD44 hi and CD44 lo cells, epithelial markers E-cadherin and ZO-1 are missing at the lamellipodia in leading edge cells but remaining membrane-localized in the rear end of leading cells at the contacting area with the follower cells, with a similar distribution of β-catenin and a reorganization of F-actin (Fig.3G, Fig. S4 ). Extensive evidence indicated that the stromal microenvironmental signals could influence cancer cell plasticity and tumorigenicity (Friedl & Alexander, 2011) . Among these signals, hypoxia and tumor associated microphage (TAM) stimulation have been shown to potently activate EMT program and cancer stemness (Chaffer et al, 2013; Gregory et al, 2011 . Results showed that the treatment of hypoxia to CD44 lo cells results in a rapid generation of a CD44 hi subpopulation, and similar results occur when isolated CD44 lo cells are cocultured with TAMs( Fig. 4C ). Conversely, CD44
expression was reduced in CD44 hi cells treated with hypoxia ( Fig. 4D ). Additionally, coculture with TAMs results in the rapid increase of CD44 levels in both of isolated CD44 lo cells and CD44 hi cells (Fig. 4C ). The results suggested that tumor microenvironment contributes to the formation of CD44 hi -leader cells in the leading front. Moreover, breast cancer microenvironment has an enhanced inflammatory network, in which IL-6 is reported to be an important regulator (Yadav et al, 2011) .
However, when rhIL6 is added to the medium, the conversion between CD44 lo and CD44 hi was not influenced, suggesting that secreted IL6 is not indispensable for generating CD44 hi leader cells from epithelial tumor (Fig. S5 ). Together, these data indicated that microenvironmental signals in individual tumor enhance the rate of interconversions between CD44 lo and CD44 hi subsets in luminal breast cancer and contribute to the generation of CD44 hi -leader cells.
The expression patterns of CD44 in the invasive CD44 hi leading-cells and the
CD44 lo following-cells
To further identify the molecular mechanisms responsible for the switch of CD44, we investigated the expression pattern of CD44 variants. This pattern was detected in a reverse transcription polymerase chain reaction (RT-PCR) assay by a primer pair spanning the entire variant region (Banky et al, 2012; Yang et al, 2015) . Our results
showed that there is no difference of CD44s expression between CD44 hi and CD44 lo cells, whereas, the mRNA levels of CD44 variants were higher in the CD44 hi cells compared with those CD44 lo cells ( 
Changes of CSC population during the CD44 switching
It is widely accepted that CSCs are contained exclusively in the CD44 hi cancer cells (Al-Hajj et al, 2003; Visvader & Lindeman, 2012 (Fig.5F ). This result implied that the switching of CD44 might not be corresponding to conversions of the stemness properties of non-CSCs-to-CSCs.
Dynamic colocalization of merlin/ezrin and CD44 enabled collective migration
Of known intracellular CD44 binding partners, ezrin and merlin were reported important in contractile transduction and assembly of cortical actin during cell migration (Fehon et al, 2010) . The distribution change of ezrin or merlin in response to various signals could control the lateral cell mobility (Chiasson-MacKenzie et al, 2015) . We then investigate how the binding partners are involved in enabling the observed collective cell movements. A confluent epithelial BrCa monolayer was cultured to generate sheet migration by scratch-wounding. In the early time points of the sheet migration, the expression of ezrin was very low at the wound edge, which was coinciding with that of CD44 ( Fig.6 A, left, Fig.S5 ). In contrast, after 72h of migration, eztin was enriched in the leading edge cells, displaying co-localization with increased CD44 and suggesting complex formation between ezrin and CD44( Fig.6A, right, Fig.S6 ). Therefore, the increased CD44-Ezrin complexes at the leader cells presumably stabilize directional cell motility. Simultaneously, within the first few minutes of wound, merlin mostly presented at cohesive cell-cell boundaries (Fig.6B, left, Fig.S6 ). Interestingly, after collectively migrating for 72h, in the leading cells, merlin molecules transferred to the cytoplasm, whereas remains stable in stationary follower cells (Fig. 6B, right, Fig.S6 ). The spatial relocalization of merlin in the cell-sheets suggested that the migration-induced cellular pulling-force triggered by leader cells resulted in a release of cortical merlin. Merlin is known to control lamellipodium formation (Das et al, 2015) . The spatial location of merlin and formation of CD44-Ezrin complexes, accompanied with CD44 switch in the moving cell-sheets, presumably stabilizes the formation of invasive lamellipodium.
Merlin/ezrin and CD44 might form a molecular switch that supports collective cell migration. conversion happened in vivo so that they achieve final equilibrium state of CD44 levels.
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Discussion
Clinically, luminal breast cancers can collectively invade as cohesive cell clusters, with about 20% of cases that eventually undergo metastasis (Kennecke et al, 2010) . The molecular basis of the transition from in situ to invasive state in breast cancer remained elusive till now. Recently, the plasticity and continuous evolving of cell populations within the same tumor bring more challenges for explanation of the mechanisms involved (Friedl & Alexander, 2011 (Godar et al, 2008; Ponta et al, 2003) . In our study, we found that the differences of CD44 levels appear to be closely related to the differences in cell molecular subtypes, with generally lower level in luminal BrCa than in basal BrCa, corresponding to its less aggressive and better prognosis than basal BrCa in clinical cases (Roswall et al, 2018) .
Additionally, in luminal BrCas, CD44 was enriched at the leading front of the invading cell strands, whereas in the inner region of the collective clusters it was maintained at a lower level. The CD44 hi cells residing have a strong impact on the overall invasive behavior of these cohesive tumor cells. Accordingly, as a tumor-promoting protein (Ahmed et al, 2016 ) and a useful CSC marker (Al-Hajj et al, 2003; Prince et al, 2007) , the spatial distribution of CD44 in invasive cell clusters, appears to be responsible for the profound differences in cell invasive ability among heterogeneous subpopulations. (Roswall et al, 2018) . In particular, there have been multiple observations about phenotype switching between subpopulations of breast cancer cells, that caused chemotherapy failure and tumor metastatic dissemination (Hanahan & Coussens, 2012; Yu et al, 2013) . Evidences revealed that CSC-like cells may arise from non-CSCs and vice versa, and the molecular subtype of breast cancer can convert from basal-like phenotype to luminal-like state, which may influence the sensitivity to chemotherapy (Iliopoulos et al, 2011; Yang et al, 2012 is related to metastatic properties whereas CD44s confers nonmetastatic properties (Morath et al, 2018; Yae et al, 2012) . CD44v isoforms are also associated with stem-like properties in many different cancers (Banky et al, 2012; Guo & Frenette, 2014; Ishimoto et al, 2011) . However, cancer cells with CD44s were showed to be more invasive and stronger drug resistance in pancreatic cancers (Zhao et al, 2016) . The isoform switching from CD44v to CD44s was reported to contribute to EMT and breast cancer progression in immortalized normal cells where CD44s, not CD44v, has been manifested to be crucial for successful complete EMT (Brown et al, 2011) . Taken together, although being disputative, the isoform switching of CD44 mediated by alternative splicing has important impact on malignant behaviors of cancer cells. Our results thus revealed that CD44 alternative splicing happens in response to the stimuli of TAMs, resulting in a shift in expression from CD44s to CD44v isoforms. Through isoform switching, the obtained high levels of CD44 isoforms might be responsible for the distinct cellular functions of cell subpopulations, including invasion and tumor-initiating ability.
CD44
Leading Cells Have CD44-Dependent Invasion Program.
We observed large, CD44-dependent differences between CD44 hi and CD44 lo subpopulations in the same luminal breast tumor. In accordance with the ability of CD44 hi cancer cells in driving collective invasion, we detected a specific molecular program in CD44 hi subpopulation. Suppression of epithelial markers (CDH1 and JUP) and upregulation of mesenchymal markers (Vim, FN1, Ptgs2, and ZEB2) occurred in the CD44 hi /leading cells. These changes are reported to be sufficient to activate complete EMT (Drees et al, 2005) . However, at the same time, upregulation of tight junction proteins claudin 1, 3, 4 and 7 was also observed in the leader cells, which is opposite to the classic EMT program (Ribeiro & Paredes, 2014 (Fortier et al, 2013) . The hybrid E/M state has been described as a metastable phenotype (Lee et al, 2006) , generating more plastic and metastable cancer cells (Klymkowsky & Savagner, 2009) . Therefore, all these alterations might improve the formation of invasive tips, leading to an increase in cell motility and invasion capacity, and orchestrate the collective movement. Although expression of CD44 is reported to be regulated by p53, p63 (Godar et al, 2008) , and ESPR1/2(Brown et al, 2011), we did not observe any difference of those genes expression during the switch of CD44 in luminal BrCa. The precise mechanisms related need further exploration.
In addition, MMP2, MMP9 and Plau expression were increased in CD44 hi /leader cells, in comparison with CD44 lo /follower cells, which were demonstrated to accelerate invasion through remodeling of the ECM. Furthermore, analysis on the distribution features showed that CD44 hi /leading cells presenting specific characteristics with some epithelial markers (E-cadherin, β-catenin, and ZO-1) were missed at the leading edge of lamellipodia, but remained at the contacting area with the following cells. Taken together, our data suggest that leader cells could possess all the gene expression required for enhanced cell invasion capacity but remain cell-cell junction with the follower cells. All these hybrid traits exhibited a transient EMT state, with an increased plasticity and invasiveness, which might be an additional explaination why EMT is dispensible for metastsis (Zheng et al, 2015) .
Merlin/Ezrin and CD44 Coordinately Regulate Collective Invasion.
Observations have suggested that, through forming coreceptor complexes with various receptors and signaling kinases, CD44 drives numerous signaling pathways in tumor-promoting effects (Godar et al, 2008 ) (Ponta et al, 2003) . Also, CD44 serves as a picket attaching the actin cytoskeleton to the plasma membrane, connecting cytoand pericellular signaling to modulate receptors mobility (Freeman et al, 2018) . In this study, confocal microscopy studies confirmed the co-localization of enriched CD44
and ezrin at the front ends of a migrating leader cell, while merlin relocalizing to the cytoplasm. Meanwhile, in the follower cells, merlin mostly concentrated at cell-cell contact sites together with E-cadherin and β-catenin. Ezrin was revealed to interact with both of CD44 and F-actin, forming a bridge between CD44 and the actin cytoskeleton, mediating changes in cell morphology and migration (Donatello et al, 2012) . Merlin was reported to act as a mechanochemical transducer, coordinating lamellipodium formation and collective movement of cell clusters during wound healing (Das et al, 2015) . Therefore, the reciprocity of Ezrin-merlin-CD44 association in migrating cell clusters may help maintain collective cell movement during breast cancer cell invasion. However, further studies are needed to clarify the mechanism.
Conclusion
In summary, the study indicated the potential values of CD44 switching and 
Cell culture and Mice
Human breast cancer cell lines MCF-7, T47D, and ZR-75-30 were bought from American Type Culture Collection (ATCC) and cultured in MEM, RPMI-1640 medium, or Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal calf serum, 100 U/ml penicillin, and 100 mg/ml streptomycin. All cells were grown to 85% confluency for experiments.
In this report, we explore the role of CD44 in tumor progression using the mouse mammary tumor virus LTR-driven polyoma middle T antigen (MMTV-PyMT) transgenic mouse, which has been proved to be a reliable model of human luminal breast cancer (Guy et al., 1992; Herschkowitz et al., 2007; Lin et al., 2003) .
MMTV-PyMT (FVB/n) mice were from Jackson Labs. All protocols involving mice were evaluated and approved by our Institutional Animal Care and Use Committee and performed under veterinary supervision.
Immunohistochemical staining of tumor samples
Formalin-fixed paraffin-embedded human breast cancer tissues were obtained from 
CCK-8 assay
The proliferation of CD44 hi and Cd44 lo cells was determined by CCK-8 kit (Dojindo, Japan). Approximately purified 3.5×10 3 cells in 100 ml were incubated in triplicate in 96-well plates. At 0, 24, 48, 72 and 96 h, the CCK-8 reagent (10 ml) was added to each well and incubated at 37°C for 2 h. The optical density at 450 nm was measured using an automatic microplate reader (Synergy4; BioTek, Winooski, VT, USA).
EdU assay
The cell proliferation was analyzed by EdU (5-ethynyl-20-deoxyuridine) assay using Cell-Light EdU DNA Cell Proliferation Kit (RiboBio, Shanghai, China). The cell proliferation rate was calculated according to the manufacturer's instructions.
Images were taken using a fluorescence microscope (Nikon). 
Mammosphere formation assay
Live imaging of cell migration assay Live imaging of cells was conducted using a
Nikon Living-Cell Observer system with a confocal microscope (Nikon A1, Tokyo, Japan). In general, images were collected at 30-min or 1h intervals with exposure times of ∼250 ms. Some of the movies were collected. Temperature was held at 37 °C and CO 2 at 5%.
Migration experiments were performed according to the method described by Das et al. (Das et al, 2015) . CD44 hi and CD44 lo cells from MCF7 cells were cultured on each dish separately with one silicone culture-insert (ibid) press-bonded to create confined wells (each well 3.25mm×7mm; growth area per well 22 mm 2 ). When cells formed 100% confluent monolayers, the insert was removed to generate cluster migration in the forward facing direction with 0.5mm wound-gap. 3×10 4 cells were seeded into each well with 80 µl cell culture medium and incubated at 37 °C in a 5%
CO 2 humidified incubator. The migration area of each cell= Cell area after 24 or 72 hours-Cell area at T0. 
RNA Sequencing
Quantitative real-time PCR
Real-time PCR was performed to validate gene expression in CD44 hi and CD44 lo cancer cells. Total RNA was extracted by RNeasy mini kit (Takara) according to the manufacturer's instructions. Purified RNA was treated with RNase-free DNaseI to ensure complete degradation of potential genomic DNA contamination, followed by the addition of 25mM EDTA and heat denaturation of the enzyme. RNA samples were reverse transcribed to cDNA with random hexamer primers using a SuperScript III First-Strand cDNA Synthesis Kit (Takara). Real-time PCR primers were designed with RealTime Design software (http://www.bio-searchtech.com) and were custom made by Invitrogen.
Analysis of CD44 expression Cells were harvested and washed with Hanks'
balanced salt solution (HBSS) supplemented with 2% bovine serum albumin, (pH 7.4).
A single cell suspension (10 6 cells/ml) was incubated with CD44-PE antibody or isotope control antibodies on ice for 1 h. Cells were washed three times and analyzed using a flow cytometer (Beckman-Coulter, Brea, USA), and at least 8,000 cells were analyzed per sample. All experiments were performed at three times.
11. Analysis of CD44 expression pattern Cells were harvested and total RNA was purified using TRIzol reagent. For reverse transcription, a random nonamer-oligo dT combination was used as the primer. To determine the CD44 expression pattern, we use a human-specific primer pair spanning the entire variant region (forward primer:
5'-AGT CAC AGA CCT GCC CAA TGC CTT T, reverse primer: 5'-TTTGCT CCA CCT TCT TGA CTC CCA TG-3' (Banky et al, 2012; Yang et al, 2015) . All CD44 variants are theoretically amplified. The PCR reaction mixture was obtained from Takara. The PCR cycling procedures were described as our previous report (Yang et al, 2015) .
The shift of CD44 in vivo
To determine the generation of CD44 hi cells from CD44 lo cells and vice versa in vivo, Statistical analysis Statistical analysis was performed using GraphPad InStat software (GraphPad Software, Inc.). Nonparametric Mann-Whitney tests were performed to measure the differences in CD44 expression, tumor formation, mammosphere-forming capacity, and invasiveness between CD44 hi and CD44 lo cells.
The significance of differences among groups was determined by one-way ANOVA t test, or Fisher exact test accordingly. Statistically significance was considered as P < 0.05. MMTV/PyMT mice, and then cultured in the wound chamber (ibid). A sheet migration of epithelial cells was generated as described before. Then, cells were fixed for Ezrin and CD44 expression at 0h and 24h post wounding by immunofluorescence assay. Representative images were presented. Scale bars, 50 μm. (B) Localization of CD44 and merlin in stationary (left) and migrating (right) monolayer. A sheet migration of epithelial cells was made as previously described. Merlin and CD44 expression at 0h and 24h post wounding were determined by immunofluorescence assay. Scale bars, 50µm. virus, separately, then examined for the wound closure. Cells were cultured in 6-well plates until they formed 100% confluent monolayers. Then a 100 mm "wound" scratches were made using a sterile pipette tip. The cells was incubated with MEM containing 1% FBS for different periods.
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Then the pictures were captured. -primary cancer cells purified from MMTV/PyMT mice, were cultured in the wound chamber (ibid). A sheet migration of epithelial cells was generated as described before.
Then, cells were fixed for CD44 and E-cadherin, orβ-catenin expression at 24h post wounding by immunofluorescence assay. Representative images were presented. Scale bar, 50 µm.
Fig. S5 Flow cytometric analysis of changes of CD44 levels after IL6 stimulation
Flow cytometric analysis of changes of CD44 levels after stimulated with rhIL-6. Purified CD44 hi or CD44 lo cells obtained from MCF7 cells were incubated in the absence or presence of rhIL-6 (50ng/ml) for 0-7days, then examined for CD44 levels by FACS. 
